ACIRA-REHOSP: Analysis of Hospitalizations One Year After Acts of CAG and PCI in the Aquitaine région - ACIRA Register Data Analysis

• Sponsor: University Hospital, Bordeaux (Other)
• Overall Status: Completed
• CT.gov ID: NCT03115723
• Collaborator: (none)
• Enrollment: 11,487
• Locations: 11
• Actual Duration (Months): 12
• Patients Per Site: 1044.3
• Patients Per Site Per Month: 86.8

Study Details

Study Description

Brief Summary

Hospital readmission rate following percutaneous coronary interventions (PCI) or coronary angiographies (CAG) is a main indicator of quality of care and addresses economic issues. The aim of this study is to quantify the frequency and analyse the types of rehospitalizations and repeat revascularizations during one year after a PCI or a CAG. This information is needed to organize the health care pathway and to identify preventable rehospitalizations.

Condition or Disease	Intervention/Treatment	Phase
Angioplasty; Coronary Angiography	Procedure: Percutaneous coronary intervention; Procedure: Coronary angiography

Study Design

• Study Type: Observational [Patient Registry]
• Actual Enrollment: 11487 participants
• Observational Model: Cohort
• Time Perspective: Prospective
• Official Title: Frequency and Characteristics of Rehospitalizations During One Year After Percutaneous Coronary Intervention and Coronary Angiography - Results of the ACIRA Registry, Aquitaine Region
• Actual Study Start Date: Jan 15, 2016
• Actual Primary Completion Date: Jan 15, 2017
• Actual Study Completion Date: Jan 15, 2017

Arms and Interventions

Arm	Intervention/Treatment
Group 1 : Percutaneous coronary intervention All the patients who underwent percutaneous coronary intervention, in 9 invasive cardiology centers in the Aquitaine Region, France.	Procedure: Percutaneous coronary intervention
Group 2 : Coronary angiography All the patients who underwent coronary angiography, in 9 invasive cardiology centers in the Aquitaine Region, France	Procedure: Coronary angiography

Outcome Measures

Primary Outcome Measures

1. Type of rehospitalization [Baseline to 1 year]

2. Number of rehospitalization [Baseline to 1 year]

Secondary Outcome Measures

1. Identification of hospitals [Baseline to 1 year]

   All hospitals concerned by initial coverage and rehospitalization

2. Type of diagnoses and procedures associated with each type of rehospitalization [Baseline to 1 year]

3. Type of cardiac rehabilitation procedures in hospitalizations for post-operative and rehabilitation wards [Baseline to 1 year]

Eligibility Criteria

Criteria

• Ages Eligible for Study: 18 Years and Older
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: No

Inclusion Criteria:

• Patients included in ACIRA Registry : All volunteer adults (≥ 18 years) and French resident patients who underwent PCI and CAG in the interventional cardiology hospitals in the Aquitaine region (France),

• Initial PCI or CAG performed from January 1, 2012 to December 31, 2013,

• Initial PCI or CAG performed in nine interventional cardiology hospitals in the Aquitaine region (France).

Exclusion Criteria:

• Patients who declined to take part of ACIRA Registry,

• Patients resident outside the Aquitaine region (France),

• Patients who died during the initial hospital stay,

• Patients hospitalized for a PCI or a CAG the month preceding the initial procedure including in the ACIRA-Rehosp study.

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Clinique Esquirol St Hilaire	Agen		France
2	Clinique cardiologique d'Aressy	Aressy		France
3	GCS Bayonne	Bayonne		France
4	Clinique de Caudéran les pins-francs	Bordeaux		France
5	Clinique de St Augustin	Bordeaux		France
6	CH de Libourne	Libourne		France
7	CH de Mont de Marsan	Mont de Marsan		France
8	CH de Pau	Pau		France
9	CH de Perigueux	Perigueux		France
10	CHU de Bordeaux	Pessac		France	33604
11	Hôpital privé St Martin	Pessac		France

Sponsors and Collaborators

• University Hospital, Bordeaux

Investigators

• Study Chair: Saillour-Glénisson Florence, MD, University Hospital, Bordeaux
• Study Director: Lesaine Emilie, MD, University Hospital, Bordeaux

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: University Hospital, Bordeaux
• ClinicalTrials.gov Identifier: NCT03115723
• Other Study ID Numbers: CHUBX 2014/29
• First Posted: Apr 14, 2017
• Last Update Posted: Feb 9, 2022
• Last Verified: Feb 1, 2022

• Individual Participant Data (IPD) Sharing Statement: No
• Plan to Share IPD: No
• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No
• Keywords provided by University Hospital, Bordeaux: Hospitalization; Health Care Economics and Organizations

Study Results

No Results Posted as of Feb 9, 2022